ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Danisco is closing a plant and reorganizing its R&D efforts in the wake of its April acquisition of the enzymes producer Genencor. The Danish food ingredients firm will close a Genencor enzymes facility in Beloit, Wis., that employs about 100 people. Half of the employees will be offered jobs at other Danisco/Genencor sites, including Cedar Rapids, Iowa, where most of the plant's output will be shifted. The shutdown of the plant, which Genencor obtained in its 2002 acquisition of Enzyme Bio-Systems, will be complete by the end of 2007, the firm says. At the same time, Danisco is merging its R&D organization with that of Genencor under a "center of excellence" model. Danisco R&D locations in Brabrand and Copenhagen, Denmark, will focus on the food and feed markets, while Genencor sites in Leiden, the Netherlands, and Palo Alto, Calif., will concentrate on industrial enzymes. About 26 positions will be eliminated across the four sites, the company says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X